1. R.J.M. Ten Berge, A.T. Natarajan, M.R. Hardeman, E.A. Van Royen, and P. Schellekens. Labelling with Indium-111 has detrimental effects on human lymphocytes: concise communication. J. Nucl. Med.; 24:615 (1983).
2. B. Fisher, B.S. Packard, E.J. Reed, J.A. Carrasquillo, C.S. Carter, S.L. Topalian, J.C. Yang, P. Yolles, S.A. Larson and S.A. Rosenberg. Tumor localization of adoptively transferred Indium-111 labelled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol.; 7:250 (1989).
3. J.P. Lavender, J.M. Goldman, R.N. Arnot and M.L. Thakur. Kinetics of Indium-111 labelled lymphocytes in normal subjects and patients with Hodgkin’s disease. Br. Med. J; 2:797 (1977).
4. K.G. Shmidt, B.S. Poulsen, J.W. Rasmussen, J. Johansen and M. Ronne. Tc-99m-HMPAO as a lymphocyte label. In: Radiolabelled cellular blood elements. Ed. H. Sinzinger and M. L. Thakur. Wiley-Liss Inc. New York. 209 (1990).
5. M. De Schrijver, K. Streule, R. Senekowistch and R. Fridrich. Scintigraphy of inflammation with nanometer-sized colloidal tracers. Nucl. Med. Comm.; 8:895 (1987).